| Application no. and date | 14714013.1 (espacenet) (Federated) (European Patent Register), 20140305 | | Patent/reg. no. and date | DK/EP 2964193, 20191211 | | Publication date | 20160113 | | Priority no. and date | US 201361772927 P, 20130305, US 201461925443 P, 20140109 | | EP pub. no. and date |
EP 2964193 20160113 | | Effective date | | | Applicant/owner | Enteris BioPharma, Inc., 83 Fulton Street
Boonton, NJ 07005, US | | Applicant ref. no. | P42000692DK00E | | Inventor | VRETTOS, John, Stanley, 305 Plymouth Road
Union, NJ 07083, US,
STERN, William, 113 Surey Lane
Tenafly, NJ 07670, US,
CARL, Stephen, M., 42 Yellowstone Lane
Howell, NJ 07731, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/216 (2006.01) , A61K 31/351 (2006.01) , A61K 31/65 (2006.01) , A61K 31/7036 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 9/08 (2006.01) , A61K 9/48 (2006.01) | | Title | Lægemidler til oral indgivelse | | Int. application no. | US2014020763 | | Int. publication no. | WO2014138241 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
